📰 Solid Biosciences Inc News
Page 7 - Solid Biosciences Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Solid Biosciences Inc. Real-time updates on events, politics, business and more.
April 16, 2023
Solid Biosciences Inc. (NASDAQ:SLDB – Get Rating) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 36,100 shares, a growth of 71.9% from the March 15th total of 21,000 shares. Currently, 0.2% of the company’s stock are sold short. Based […]
March 28, 2023
MaxCyte Inc on Tuesday said it appointed Douglas Swirsky as its new chief financial officer, effective immediately. The Maryland, US-based cell-engineering focused company said Swirsky previously... | March 28, 2023
March 27, 2023
ROCKVILLE, Md., March 27, 2023 -- MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization... | March 27, 2023
January 11, 2023
Research collaboration to target severe form of genetic dilated cardiomyopathyCollaboration strengthens Solid Biosciences’ scientific capabilities and commercial potential in cardiac... | January 11, 2023
December 5, 2022
05.12.2022 - - Transactions create a precision genetic medicine company focused on neuromuscular and cardiac diseases, led by industry veteran Bo Cumbo - - Company to leverage synergies and key assets, including product candidates for Duchenne muscular ... Seite 1
November 15, 2022
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
November 10, 2022
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
November 7, 2022
NEW YORK, Nov. 06, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...
November 2, 2022
Gene therapy clinical trial pipeline constitutes 250+ key companies continuously working towards developing 300+ gene therapies, analyzes DelveInsight LAS VEGAS, Nov. 2, 2022 /PRNewswire/
November 2, 2022
/PRNewswire/ -- DelveInsights Gene Therapy Competitive Landscape – 2022 report provides comprehensive global coverage of available, marketed, and pipeline...